Arthracam® (Artrakam®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceGlucosamineGlucosamine
Similar drugsTo uncover
  • Arthracam®
    powder inwards 
    Inkamfarm, OOO     Russia
  • Glucosamine
    powder inwards 
    ATOLL, LLC     Russia
  • Glucosamine
    powder inwards 
    FARMAKOR PRODUCTION, LTD.     Russia
  • Glucosamine
    pills inwards 
    ATOLL, LLC     Russia
  • Glucosamine sulfate 750
    pills inwards 
    Unipharm, Inc.     USA
  • DONA®
    pills inwards 
    Rottafarm SpA     Italy
  • DONA®
    solution w / m 
    Rottafarm SpA     Italy
  • DONA®
    powder inwards 
    Rottafarm SpA     Italy
  • Sustagard® Artro
    solution w / m 
    FarmSirma Soteks, ZAO     Russia
  • Sustilac
    pills inwards 
    REMEDIYA, LLC     Russia
  • Chondroxide® Maximum
    cream externally 
    Spring Vast Investments Limited     Singapore
  • Elbona®
    solution w / m 
    ELLARA, LTD.     Russia
    • Dosage form: & nbspPowder for solution for oral administration
    Composition:

    One packet contains:

    active substance: glucosamine sulfate sodium chloride in terms of 100% substance 1.884 g, including glucosamine sulfate - 1.5 g.

    Excipients: sorbitol - 0.296 g, citric acid - 0.02 g.

    Description:White or white with a slightly yellowish tinge powder.
    Pharmacotherapeutic group:Reparation of tissue stimulant
    ATX: & nbsp

    M.01.A.X.05   Glucosamine

    Pharmacodynamics:

    Glucosamine sulfate has an anti-inflammatory and analgesic effect, replenishes the endogenous deficiency of glucosamine, stimulates the synthesis of proteoglycans and hyaluronic acid synovial fluid; increases the permeability of the joint capsule,restores enzymatic processes in the cells of the synovial membrane and articular cartilage. Promotes fixation of sulfur during the synthesis of chondroitinsulfuric acid, inhibits the development of degenerative processes in the joints, restores their function, reducing joint pain.

    Pharmacokinetics:

    Absorption in the gastrointestinal tract 90%, bioavailability 26%, half-life 70 hours.

    Indications:

    Osteoarthritis of peripheral joints, and joints of the spine, osteochondrosis.

    Contraindications:

    Individual hypersensitivity to glucosamine sulfate and other components of the drug. Severe chronic renal failure, pregnancy, lactation.

    It is not recommended to prescribe the drug in childhood (up to 12 years) because of the lack of clinical data in this category of patients.

    Carefully:

    With intolerance to seafood (shrimp, shellfish), the likelihood of allergic reactions to the drug increases. Bronchial asthma, diabetes mellitus.

    Dosing and Administration:

    Inside. The contents of one sachet are dissolved in 200 ml of water, taken orally once a day for 6 weeks. On the appointment of a doctor, the course of treatment can be repeated at intervals of 2 months.

    Side effects:

    Drug tolerance is good, in some cases, possible: gastralgia, flatulence, diarrhea, constipation, allergic reactions - urticaria, pruritus.

    Overdose:

    Cases of overdose are unknown. Treatment: gastric lavage, symptomatic therapy.

    Interaction:

    Compatible with non-steroidal anti-inflammatory drugs, paracetamol and glucocorticosteroids. Increases the absorption of tetracyclines, reduces - semisynthetic penicillins, chloramphenicol.

    Effect on the ability to drive transp. cf. and fur:Data on the impact on the ability to drive vehicles and work with mechanisms are missing.
    Form release / dosage:

    Powder for solution for oral administration 1.5 g.

    Packaging:

    2.2 grams in packages heat-sealing from the combined material "Ceften" brand HC50CA7RT30 according to the documentation of the manufacturer "Sopal", France or "Buflen" according to TU 5453-046-45982064-2003. 20 packages together with the instruction for use are placed in a pack of cardboard in accordance with GOST 7933-89 or GOST 123-01-81 or GOST 123-03-80, GOST 64-071-89.

    Group packing and transport packaging in accordance with GOST 17768-90.

    Storage conditions:In the dark place at a temperature of no higher than 25 ° C.Keep out of the reach of children.
    Shelf life:3 years. Do not use after expiry date.
    Terms of leave from pharmacies:Without recipe
    Registration number:LSR-008621/09
    Date of registration:28.10.2009 / 08.12.2015
    Expiration Date:Unlimited
    The owner of the registration certificate:Inkamfarm, OOOInkamfarm, OOO Russia
    Manufacturer: & nbsp
    Information update date: & nbsp13.09.2017
    Illustrated instructions
      Instructions
      Up